Your browser doesn't support javascript.
loading
Treatment outcomes, health-care resource utilization and costs of bortezomib and dexamethasone, with cyclophosphamide or lenalidomide, in newly diagnosed multiple myeloma.
Kumar, S K; Ma, E; Engebretson, A E; Buadi, F K; Lacy, M Q; Dispenzieri, A; Duh, M S; Lafeuille, M-H; Lefebvre, P; Cheng, W Y; Dea, K; Rembert, D; Patt, D; Niculescu, L; Quick, M; Rajkumar, S V.
Afiliação
  • Kumar SK; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Ma E; Millennium Pharmaceuticals Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.
  • Engebretson AE; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Buadi FK; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Lacy MQ; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Dispenzieri A; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Duh MS; Analysis Group, Inc, Boston, MA, USA.
  • Lafeuille MH; Analysis Group, Inc, Boston, MA, USA.
  • Lefebvre P; Groupe d'analyse, Ltée, Montreal, QC, Canada.
  • Cheng WY; Analysis Group, Inc, Boston, MA, USA.
  • Dea K; Groupe d'analyse, Ltée, Montreal, QC, Canada.
  • Rembert D; McKesson Specialty Health, The Woodlands, TX, USA.
  • Patt D; McKesson Specialty Health, The Woodlands, TX, USA.
  • Niculescu L; Millennium Pharmaceuticals Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.
  • Quick M; Millennium Pharmaceuticals Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.
  • Rajkumar SV; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Leukemia ; 30(4): 995-8, 2016 Apr.
Article em En | MEDLINE | ID: mdl-26271606

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Custos de Cuidados de Saúde / Recursos em Saúde / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Implementation_research Limite: Humans Idioma: En Revista: Leukemia Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Custos de Cuidados de Saúde / Recursos em Saúde / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Implementation_research Limite: Humans Idioma: En Revista: Leukemia Ano de publicação: 2016 Tipo de documento: Article